Dr Myriam Chimen has been awarded a 5-year Royal Society Dorothy Hodgkin Research Fellowship to investigate the glucocorticoid regulation of a novel pathway controlling T-cell trafficking in chronic inflammatory diseases and ageing.
Dr Myriam Chimen has been awarded a 5-year Royal Society Dorothy Hodgkin Research Fellowship to investigate the glucocorticoid regulation of a novel pathway controlling T-cell trafficking in chronic inflammatory diseases and ageing.
Myriam completed her PhD with Dr Parth Narendran and Professor Ed Rainger at the University of Birmingham. Her studies lead to the discovery of a novel peptide inhibitor of trans-endothelial migration (PEPITEM) and she characterised this novel pathway in health and patients with chronic inflammatory diseases. She continued her postdoctoral training at the University of Birmingham with Prof Ed Rainger on the modulation of foam cell formation in atherosclerosis. She is part of the Leukocyte Trafficking group and her research will focus on understanding how immune regulatory pathways change with age and chronic inflammation.
